Iterum Therapeutics Statistics

Total Valuation

ITRM has a market cap or net worth of $40.46 million. The enterprise value is $64.01 million.

Market Cap	40.46M
Enterprise Value	64.01M

Important Dates

The next estimated earnings date is Monday, May 12, 2025, before market open.

Earnings Date	May 12, 2025
Ex-Dividend Date	n/a

Share Statistics

ITRM has 34.58 million shares outstanding. The number of shares has increased by 51.97% in one year.

Current Share Class	34.58M
Shares Outstanding	34.58M
Shares Change (YoY)	+51.97%
Shares Change (QoQ)	+33.14%
Owned by Insiders (%)	1.19%
Owned by Institutions (%)	7.74%
Float	33.84M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	6.62
PB Ratio	-10.42
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.41

Current Ratio	1.41
Quick Ratio	1.37
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-7.41

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-32.98%
Return on Invested Capital (ROIC)	-42.78%
Return on Capital Employed (ROCE)	-69.27%
Revenue Per Employee	n/a
Profits Per Employee	-$2.75M
Employee Count	9
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, ITRM has paid $240,000 in taxes.

Income Tax	240,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -22.07% in the last 52 weeks. The beta is 2.44, so ITRM's price volatility has been higher than the market average.

Beta (5Y)	2.44
52-Week Price Change	-22.07%
50-Day Moving Average	1.43
200-Day Moving Average	1.40
Relative Strength Index (RSI)	30.75
Average Volume (20 Days)	256,428

Short Selling Information

The latest short interest is 1.53 million, so 4.43% of the outstanding shares have been sold short.

Short Interest	1.53M
Short Previous Month	1.58M
Short % of Shares Out	4.43%
Short % of Float	4.53%
Short Ratio (days to cover)	5.19

Income Statement

Revenue	n/a
Gross Profit	-254,000
Operating Income	-18.70M
Pretax Income	-35.05M
Net Income	-24.77M
EBITDA	-18.41M
EBIT	-18.70M
Earnings Per Share (EPS)	-$1.26

Full Income Statement

Balance Sheet

The company has $24.13 million in cash and $45.60 million in debt, giving a net cash position of -$21.48 million or -$0.62 per share.

Cash & Cash Equivalents	24.13M
Total Debt	45.60M
Net Cash	-21.48M
Net Cash Per Share	-$0.62
Equity (Book Value)	-4.08M
Book Value Per Share	-0.13
Working Capital	7.18M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$26.77 million and capital expenditures -$2,000, giving a free cash flow of -$26.77 million.

Operating Cash Flow	-26.77M
Capital Expenditures	-2,000
Free Cash Flow	-26.77M
FCF Per Share	-$0.77

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ITRM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-51.97%
Shareholder Yield	n/a
Earnings Yield	-58.24%
FCF Yield	-62.94%

Analyst Forecast

The average price target for ITRM is $5.00, which is 327.35% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$5.00
Price Target Difference	327.35%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on August 18, 2022. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date	Aug 18, 2022
Split Type	Reverse
Split Ratio	0.0666667:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a